(MMYT) MakeMyTrip - Overview
Exchange: NASDAQ •
Country: India •
Currency: USD •
Type: Common Stock •
ISIN: MU0295S00016
Stock: Travel Bookings, Flights, Hotels, Buses, Packages
Total Rating 25
Risk 37
Buy Signal -1.46
| Risk 5d forecast | |
|---|---|
| Volatility | 59.4% |
| Relative Tail Risk | -6.20% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.99 |
| Alpha | -61.52 |
| Character TTM | |
|---|---|
| Beta | 0.891 |
| Beta Downside | -0.540 |
| Drawdowns 3y | |
|---|---|
| Max DD | 59.63% |
| CAGR/Max DD | 0.42 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 96.75
Description: MMYT MakeMyTrip March 04, 2026
MakeMyTrip Limited (MMYT) is an online travel agency (OTA) operating across India, Southeast Asia, and other international markets. OTAs typically generate revenue through commissions on bookings and advertising.
MMYT offers a range of travel services including air ticketing, hotels, packages, bus and rail tickets, and car hire. The company also facilitates access to travel insurance, foreign currency exchange, and visa services. This comprehensive offering is common among major travel platforms.
The company operates under multiple brands, including MakeMyTrip, Goibibo, and redBus, reaching customers through websites, mobile applications, call centers, and a network of physical agents. The multi-brand strategy allows for market segmentation and broader reach.
MMYT serves both leisure and corporate travelers. Understanding the companys market share within Indias growing travel sector is crucial; further research on ValueRay can provide detailed competitive analysis.
Headlines to watch out for
- Indian domestic travel demand fuels bookings
- Hotel and package segment growth drives revenue
- Competition from global online travel agencies impacts market share
- Regulatory changes in Indian travel sector create uncertainty
- Fuel price fluctuations influence airline and bus ticket costs
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 56.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 7.03 > 1.0 |
| NWC/Revenue: 50.82% < 20% (prev 73.15%; Δ -22.34% < -1%) |
| CFO/TA 0.12 > 3% & CFO 223.9m > Net Income 56.8m |
| Net Debt (1.25b) to EBITDA (187.8m): 6.65 < 3 |
| Current Ratio: 1.85 > 1.5 & < 3 |
| Outstanding Shares: last quarter (99.3m) vs 12m ago -13.97% < -2% |
| Gross Margin: 73.41% > 18% (prev 0.72%; Δ 7.27k % > 0.5%) |
| Asset Turnover: 56.61% > 50% (prev 51.64%; Δ 4.98% > 0%) |
| Interest Coverage Ratio: 1.67 > 6 (EBITDA TTM 187.8m / Interest Expense TTM 95.9m) |
Altman Z'' -3.93
| A: 0.28 (Total Current Assets 1.15b - Total Current Liabilities 617.9m) / Total Assets 1.86b |
| B: -1.52 (Retained Earnings -2.82b / Total Assets 1.86b) |
| C: 0.09 (EBIT TTM 159.7m / Avg Total Assets 1.84b) |
| D: -1.37 (Book Value of Equity -2.93b / Total Liabilities 2.14b) |
| Altman-Z'' Score: -3.93 = D |
Beneish M -3.11
| DSRI: 1.00 (Receivables 169.9m/152.8m, Revenue 1.04b/935.8m) |
| GMI: 0.98 (GM 73.41% / 71.67%) |
| AQI: 0.91 (AQ_t 0.37 / AQ_t-1 0.41) |
| SGI: 1.11 (Revenue 1.04b / 935.8m) |
| TATA: -0.09 (NI 56.8m - CFO 223.9m) / TA 1.86b) |
| Beneish M-Score: -3.11 (Cap -4..+1) = AA |
What is the price of MMYT shares?
As of March 12, 2026, the stock is trading at USD 48.63 with a total of 880,060 shares traded.
Over the past week, the price has changed by -3.38%, over one month by -20.25%, over three months by -39.64% and over the past year by -47.14%.
Over the past week, the price has changed by -3.38%, over one month by -20.25%, over three months by -39.64% and over the past year by -47.14%.
Is MMYT a buy, sell or hold?
MakeMyTrip has received a consensus analysts rating of 4.40.
Therefore, it is recommended to buy MMYT.
- StrongBuy: 5
- Buy: 4
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MMYT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 101.9 | 109.5% |
| Analysts Target Price | 101.9 | 109.5% |
MMYT Fundamental Data Overview March 11, 2026
P/E Trailing = 96.75
P/S = 4.6057
P/B = 277.8397
P/EG = -0.21
Revenue TTM = 1.04b USD
EBIT TTM = 159.7m USD
EBITDA TTM = 187.8m USD
Long Term Debt = 1.18b USD (from longTermDebt, last quarter)
Short Term Debt = 234.8m USD (from shortTermDebt, last quarter)
Debt = 1.68b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.25b USD (from netDebt column, last quarter)
Enterprise Value = 5.66b USD (4.79b + Debt 1.68b - CCE 814.1m)
Interest Coverage Ratio = 1.67 (Ebit TTM 159.7m / Interest Expense TTM 95.9m)
EV/FCF = 25.26x (Enterprise Value 5.66b / FCF TTM 223.9m)
FCF Yield = 3.96% (FCF TTM 223.9m / Enterprise Value 5.66b)
FCF Margin = 21.55% (FCF TTM 223.9m / Revenue TTM 1.04b)
Net Margin = 5.46% (Net Income TTM 56.8m / Revenue TTM 1.04b)
Gross Margin = 73.41% ((Revenue TTM 1.04b - Cost of Revenue TTM 276.4m) / Revenue TTM)
Gross Margin QoQ = 70.28% (prev 77.54%)
Tobins Q-Ratio = 3.04 (Enterprise Value 5.66b / Total Assets 1.86b)
Interest Expense / Debt = 2.05% (Interest Expense 34.5m / Debt 1.68b)
Taxrate = 44.63% (5.87m / 13.2m)
NOPAT = 88.4m (EBIT 159.7m * (1 - 44.63%))
Current Ratio = 1.85 (Total Current Assets 1.15b / Total Current Liabilities 617.9m)
Debt / Equity = -5.93 (negative equity) (Debt 1.68b / totalStockholderEquity, last quarter -283.6m)
Debt / EBITDA = 6.65 (Net Debt 1.25b / EBITDA 187.8m)
Debt / FCF = 5.58 (Net Debt 1.25b / FCF TTM 223.9m)
Total Stockholder Equity = 182.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.09% (Net Income 56.8m / Total Assets 1.86b)
RoE = 31.18% (Net Income TTM 56.8m / Total Stockholder Equity 182.0m)
RoCE = 11.76% (EBIT 159.7m / Capital Employed (Equity 182.0m + L.T.Debt 1.18b))
RoIC = 6.26% (NOPAT 88.4m / Invested Capital 1.41b)
WACC = 7.10% (E(4.79b)/V(6.47b) * Re(9.20%) + D(1.68b)/V(6.47b) * Rd(2.05%) * (1-Tc(0.45)))
Discount Rate = 9.20% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -6.11%
[DCF] Terminal Value 84.24% ; FCFF base≈170.7m ; Y1≈210.6m ; Y5≈358.7m
[DCF] Fair Price = 68.65 (EV 7.40b - Net Debt 1.25b = Equity 6.15b / Shares 89.6m; r=7.10% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 83.81 | EPS CAGR: 77.32% | SUE: 2.24 | # QB: 2
Revenue Correlation: 91.88 | Revenue CAGR: 21.44% | SUE: -0.65 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.50 | Chg7d=+0.000 | Chg30d=-0.051 | Revisions Net=-1 | Analysts=2
EPS next Year (2027-03-31): EPS=2.16 | Chg7d=+0.000 | Chg30d=-0.046 | Revisions Net=-3 | Growth EPS=+31.0% | Growth Revenue=+17.5%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.2% (Discount Rate 9.2% - Earnings Yield 1.0%)
[Growth] Growth Spread = +7.2% (Analyst 15.3% - Implied 8.2%)
P/S = 4.6057
P/B = 277.8397
P/EG = -0.21
Revenue TTM = 1.04b USD
EBIT TTM = 159.7m USD
EBITDA TTM = 187.8m USD
Long Term Debt = 1.18b USD (from longTermDebt, last quarter)
Short Term Debt = 234.8m USD (from shortTermDebt, last quarter)
Debt = 1.68b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.25b USD (from netDebt column, last quarter)
Enterprise Value = 5.66b USD (4.79b + Debt 1.68b - CCE 814.1m)
Interest Coverage Ratio = 1.67 (Ebit TTM 159.7m / Interest Expense TTM 95.9m)
EV/FCF = 25.26x (Enterprise Value 5.66b / FCF TTM 223.9m)
FCF Yield = 3.96% (FCF TTM 223.9m / Enterprise Value 5.66b)
FCF Margin = 21.55% (FCF TTM 223.9m / Revenue TTM 1.04b)
Net Margin = 5.46% (Net Income TTM 56.8m / Revenue TTM 1.04b)
Gross Margin = 73.41% ((Revenue TTM 1.04b - Cost of Revenue TTM 276.4m) / Revenue TTM)
Gross Margin QoQ = 70.28% (prev 77.54%)
Tobins Q-Ratio = 3.04 (Enterprise Value 5.66b / Total Assets 1.86b)
Interest Expense / Debt = 2.05% (Interest Expense 34.5m / Debt 1.68b)
Taxrate = 44.63% (5.87m / 13.2m)
NOPAT = 88.4m (EBIT 159.7m * (1 - 44.63%))
Current Ratio = 1.85 (Total Current Assets 1.15b / Total Current Liabilities 617.9m)
Debt / Equity = -5.93 (negative equity) (Debt 1.68b / totalStockholderEquity, last quarter -283.6m)
Debt / EBITDA = 6.65 (Net Debt 1.25b / EBITDA 187.8m)
Debt / FCF = 5.58 (Net Debt 1.25b / FCF TTM 223.9m)
Total Stockholder Equity = 182.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.09% (Net Income 56.8m / Total Assets 1.86b)
RoE = 31.18% (Net Income TTM 56.8m / Total Stockholder Equity 182.0m)
RoCE = 11.76% (EBIT 159.7m / Capital Employed (Equity 182.0m + L.T.Debt 1.18b))
RoIC = 6.26% (NOPAT 88.4m / Invested Capital 1.41b)
WACC = 7.10% (E(4.79b)/V(6.47b) * Re(9.20%) + D(1.68b)/V(6.47b) * Rd(2.05%) * (1-Tc(0.45)))
Discount Rate = 9.20% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -6.11%
[DCF] Terminal Value 84.24% ; FCFF base≈170.7m ; Y1≈210.6m ; Y5≈358.7m
[DCF] Fair Price = 68.65 (EV 7.40b - Net Debt 1.25b = Equity 6.15b / Shares 89.6m; r=7.10% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 83.81 | EPS CAGR: 77.32% | SUE: 2.24 | # QB: 2
Revenue Correlation: 91.88 | Revenue CAGR: 21.44% | SUE: -0.65 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.50 | Chg7d=+0.000 | Chg30d=-0.051 | Revisions Net=-1 | Analysts=2
EPS next Year (2027-03-31): EPS=2.16 | Chg7d=+0.000 | Chg30d=-0.046 | Revisions Net=-3 | Growth EPS=+31.0% | Growth Revenue=+17.5%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.2% (Discount Rate 9.2% - Earnings Yield 1.0%)
[Growth] Growth Spread = +7.2% (Analyst 15.3% - Implied 8.2%)